SlideShare a Scribd company logo
Infertility
DR KAVERI
Associate Professor
DEPT OF OBGY
GIMS
DEFINITION
• After one year of frequent, unprotected
sexual intercourse there is no conception or
maintenance of pregnancy
• INCIDENCE : 15 – 30% couples
SUBFERTILITY
• Inability to conceive after one year of
regular unprotected intercourse in the
absence of known reproductive pathology.
• Peak monthly pregnancy rate ~ 30%
• Cumulative rate in 1 year ~ 85%
• Cumulative rate in 2 years ~ 95%
• FECUNDABILITY : probability that a cycle
will result in pregnancy.
• FECUNDITY : probability that a cycle will
result in a live birth.
• In a normal fertile couple - 20% to 30%
Types of Infertility
• PRIMARY INFERTILITY: Patients who
have never conceived
• SECONDARY INFERTILITY : Previous
pregnancies but failure to conceive
subsequently
ETIOLOGY
• Male factors: 30%
• Female: 45%
• Tubal: 20%
• Ovulatory disorders: 25%
• Uterine: 10%
• Endometriosis: 5%
• Unexplained:25%
• Combined male and female: 40%
SPERMATOGENESIS
• 74 days from spermatocyte stage
• Transport 12-21 days
HORMONE REGULATION
Causes of Male Infertility
• 1. IDIOPATHIC (40-50%)
• 2. HYPOTHALAMIC & PITUITARY
DISORDERS (1-2%) Pre – Testicular
• 3. PRIMARY GONADAL DISORDERS (30-40%)
Testicular
• 4. SPERM TRANSPORT DISORDERS (10-
20%) Post - Testicular
PRE – TESTICULAR CAUSES
Hypothalamic & pituitary disorders (1-2%)
CONGENITAL
• Idiopathic isolated
gonadotropin
deficiency(M/C)
• Kallmann syndrome
• Single gene mutations
• Multiorgan genetic
disorders:
PraderWilli syndrome
Laurence Moon Beidl
syndrome.
ACQUIRED
• • Hth & pit tumors
• • Infilterative diseases
• • Hyperprolactinemia
• • Drugs
• • Critical illness
• • Chronic systemic illness
• • Infections
• • Obesity
TESTICULAR CAUSES
Primary gonadal disorders (30-40%)
• CONGENITAL
• Klinefelter syndrome
• Y chromosome deletions
• Single gene mutations
• Cryptorchidism
• Varicoceles
• Androgen insensitivity
syndromes
• 5 alpha reductase
deficiency
• ACQUIRED
• Infection(mumps orchitis)
• Drugs
• Radiation
• Gonadotoxins
• Chronic illness
• Hyperthermia
• Immunologic disorders
• Trauma
• Torsion
• Castration
Post Testicular causes
SPERM TRANSPORT DISORDERS (10-20%)
• • Epididymal obstruction or dysfunction
• • Hypospadias
• • CBAVD
• • Infections
• • Vasectomy, herniorraphy
• • Kartagener syndrome
• • Young syndrome
• • Ejaculatory dysfunction
MALE INFERTILITY EVALUATION
• ●History
• ●Examination
• ●Investigation
• 1. Conventional Semen analyses
• 2. Specialized Semen analysis
• 3. Endocrine testing
• 4. Genetic tests
HISTORY
Focuses on causes of infertility.
• Personal:
Age, occupation, special habits
• Present:
Type of infertility, duration
• Sexual:
Frequency, erection, ejaculation, dysparunia,
habits, libido.
History
Past:
• Medical:
Chronic medical illness
Infections: mumps orchitis, sinopulmonary symptoms,
STI, and GUI (prostatitis)
• Surgical:
inguinal and scrotal areas such as vasectomy,
orchiectomy, and herniorrhaphy
• Trauma
• Developmental:
testicular descent, pubertal development, loss of body
hair, or decrease in shaving frequency
History
• Drugs and environmental exposures
alcohol, radiation therapy, anabolic steroids,
cytotoxic chemotherapy, drugs that cause
hyperprolactinemia, exposure to toxic
chemicals.
• School performance : determine if he has a
history of learning disabilities
Examination
• General physical examination : general built ,
nutrition, skin & hair, sec sexual characteristics,
habitus & breast development.
• Examination of penis, location of urethral
meatus
• Palpation of testes & size
• Presence & consistency of vas & epididymis
• Digital rectal Examination
Semen analysis
A. Macroscopic
• 1. Delayed liquefaction
• 2. Increased viscosity
• 3. Semen volume
• 4. pH
B. Microscopy
• 1. Agglutination
• 2. Concentration
• 3. Motility
• 4. Morphology
• 5. Round cells
• 6. Leukocytes
Normal Semen Analysis Results
(WHO)
• Volume >2ml
• pH 7-8
• Concentration >20 x 106/ml
• Motility >50% forward & >25% with
rapid linear progress
• Morphology > 15% normal
• Alive > 50%
• Antisperm antibodies Negative
• WCC < 1x106
• II. SPECIALIZED SEMEN ANALYSIS
Not routinely performed
used to determine the cause of male infertility
• 1. Sperm autoantibodies
• 2. Semen Fructose
• 3. Semen culture
• 4. Sperm function tests
CASA
SDNAF
Investigations
• III. ENDOCRINE
TESTS
1. Testosterone
2. LH and FSH
3. Prolactin
• IV. GENETIC TESTS
1. Karyotyping
2. Y chromosome
microdeletions
3. Cystic fibrosis
conductance regulator
(CFTR) gene mutation
Semen Analysis
Abnormalities of Semen Analysis
• Azoospermia : Complete absence of sperm
on std microscopic examination in
ejaculate.
• Oligospermia : sperm density < 20
million/ml.
• Asthenospermia : Poor sperm motility.
• Teratospermia : > 70% abnormal
morphology.
• Necrospermia : dead sperm.
• Leucocytospermia > 1million leucocytes/ml
Urologic evaluation
• Physical examination
• TRUS (transrectal usg for duct obstruction)
• Transscrotal Usg
• Renal Scan
• Testis Biopsy in azoospermic men
• Vasogram
MEDICAL TREATMENT
Hypogonadotropic Hypogonadism:
• Hyperprolactinoma- Dopamine agonists
• Cong hypogonadotropic hypogonadism- hCG or
exogenous testosterone
• Adult onset hypogonadotropin hypogonadism-
hCG 2000-5000 IU 3 times per week.
Hypogonadotropin hypogonadism unrelated to
cause- Portable programmable pulsatile infusion
pump s/c
Eugonadotropin Hypogonadism
• Severe oligospermia
• Low Sr. testosterone
• T/t by aromatase inhibitor (Testolactone 50-
100 mg BD or Anastrazole 1 mg OD)
Hypergonadotropic Hypogonadism
• Insemination with donor sperm
• IVF with ICSI with preliminary genetic
evaluation
Erectile dysfunction :Sildenafil- 25-100mg
1hr before intercourse
Retrograde Ejaculation-
• Sympathomimetics, pseudoephidrine, ephedrine
• IVF & IUI & ICSI
Leucocytospermia-
• Antibiotics (doxycycline, erythromycin,
cotrimoxazole
Idiopathic Male Infertility-
• Androgen therapy
• Exogenous FSH
• Clomiphene citrate (25 mg)/Tamoxifen (20 mg)
SURGICAL TREATMENT
1. Vasovasostomy & vasoepididymostomy- In
vasectomized men
2. Transurethral resection of the ejaculatory ducts- in
men with Ejaculatory duct obstruction.
3. Varicocele repair- In men with varicoceles.
4. Orchipexy – In cryptorchidism
5. Vibratory stimulation & Electroejaculation – In
neurological dysfunctions
3-Reproductive Technique (ART)
• I- Intrauterine Insemination (IUI)
• II- IVF/ICSI
ARTIFICIAL INSEMINATION
• Indications :
• Oligospermia,
• Asthenospermia,
• Premature or retrograde ejaculation,
• Sperm autoantibodies & cervical factors,
• Unexplained infertility
• Sex selection in genetic & chromosomal anomalies
• Hypospadias
• HIV positive
Types:
• 1. IUI
• 2. Intracervical
• 3. Pericervical & Vaginal
• 4. DIPI (Direct intraperitoneal insemination
Implementation and
Collaborative Care
• Sperm Washing for Intrauterine
Insemination (IUI)
– Ejaculate is centrifuged to concentrate sperm,
which are then rinsed with saline to remove the
seminal fluid
– Sperm are again centrifuged, and then used for
either IVF or Intrauterine artificial insemination
IUI
Implementation and
Collaborative Care
• Intrauterine Insemination (a form of
artificial insemination)
– Sperm are collected within 3 hours of colitus
and are inserted via a catheter into the uterus
– Donor sperm may be used
– Identify of the sperm donor is kept confidential
Donor Sperm
INDICATIONS :
• 1. Azoospermia
• 2. Immunological factors not correctable
• 3. Genetic disease in husband
Female infertility
• ovulatory dysfunction
• tubal and peritoneal factors
• cervical factors
• Uterine factors
• others
• unexplained infertility
Ovarian disorders
Ovulatory disorders:
Infrequent ovulation (oligoovulation)
or
absent ovulation (anovulation)
Oocyte aging:
Ovarian cysts:
PCOS
Rotterdam Criteria (2 out of 3)
Menstrual irregularity due to
anovulation or oligo-ovulation
Evidence of clinical or biochemical
hyperandrogenism
Polycystic ovaries by US
• presence of 12 or more follicles in each ovary
measuring 2 to 9 mm in diameter and/or increased
ovarian volume.
Ovarian failure
Causes
• 1. Idiopathic.
• 2. Genetic.
• 3. Autoimmune
• 3. Viral/bacterial infection
• 4. Pelvic surgery, chemotherapy
• 5. Galactosemia
Tubal factors
• Tubal disease and pelvic adhesions prevent
normal transport of the oocyte and sperm
through the fallopian tube.
• PID
• Severe endometriosis
• Previous surgery or non-tubal infection (eg,
appendicitis, inflammatory bowel disease),
• Pelvic TB
Endometriosis
Uterine factors
Impaired implantation, either mechanical or
due to reduced endometrial receptivity, are the
basis of uterine causes of infertility.
Uterine leiomyomata:A meta-analysis showed
that only leiomyomata with a submucosal or
intracavitary component were associated with
lower pregnancy and implantation rates.
Uterine anomalies; Uterine abnormalities are
thought to cause infertility by interfering with
normal implantation. Müllerian anomalies are a
significant cause of (RPL), with the septate
uterus associated with the poorest reproductive
outcome .
Other structural abnormalities
endometrial polyps
synechiae from prior pregnancy related
curettage.
CERVICAL FACTORS
Normal midcycle cervical mucus
facilitates the transport of sperm.
Congenital malformations and trauma
to the cervix (including surgery) may result in
stenosis and inability of the cervix to produce
normal mucus, thereby impairing fertility.
UNEXPLAINED
Unexplained infertility is the diagnosis
given to couples after a thorough evaluation
has not revealed a cause.
Many cases of unexplained infertility may
be due to small contributions from multiple
factors.
History-General
• Both couples should be present
• Age
• Previous pregnancies by each partner
• Duration of infertility
• Sexual history
Frequency and timing of intercourse
Use of lubricants
Impotence, dyspareunia
• Contraceptive history
History-Female
• Previous female pelvic surgery
• PID
• Appendicitis
• IUD use
• Ectopic pregnancy history
• Endometriosis
• Leiomyoma
History
• Irregular menses, amenorrhea, detailed
menstrual history
• Molimina
• Vasomotor symptoms
• Changes of hair growth, breast discharge
• Stress
• Weight changes
• Exercise-drug –radiation -chemotherapy
• Cervical and uterine surgery
Physical Exam-Female
• Thyroid exam
• BMI
• Hair distribution
• Galactorrhea
• Scar in the abdomen
• Pelvic masses
• Uterosacral nodularity
• Abdominopelvic tenderness
• Uterine enlargement
• Uterine mobility
• Cervical abnormalities
• Abnormal vaginal discharge
Investigations
Assessment of ovulation
• Basal body temperature
• Urine LH kits
• Mid luteal serum progesterone
• Routine hormonal profile: FSH, LH,Prolactin,TSH
• Endometrial biopsy
• Serial pelvic Ultrasonography
• Evidence of ovulation:
1. Menstrual history of regular cycles.
2. Serum progesterone in the mid-luteal phase of
their cycle (day 21 of a 28-day cycle) even if they
have regular menstrual cycles.
3. Serum gonadotrophins ( FSH & LH) on Day2-3
especially in irregular periods.
No role for basal body temperature
Ovarian reserve tests
More important in >35 years old, suspected ovarian
failure and to detect response to ovulation induction.
• 1. Total antral follicle count.
• 2. AMH of less than or equal to 5.4 pmol/l for a
low response and greater than or equal to 25 pmol/l
for a high response
• 3. FSH greater than 8.9 IU/l for a low response
and less than 4 IU/l for a high response.
Ovarian Reserve Tests
Investigations of tubal factor
• Hysterosalpingography (HSG)
• Hysterosalpingo-contrast
sonography(HyCoSy)
• Laparoscopy with chromotubation
• Hydrolaparoscopy.
• Fluoroscopic/hysteroscopic- selective tubal
cannulation.
• Falloposcopy
Diagnostic Studies –
Female
• Hysterosalpingogram (HSG)
– Detects uterine anomalies (septate, unicornate,
bicornate)
– Detects Tubal anomalies or blockage
– Iodine-based radio-opaque dye is instilled
through a catheter into the uterus and tubes to
outline these structures and x-rays are taken to
document findings
Tubal Patency Tests
HSG
Diagnostic Studies –
Female
• Laparoscopy
– General or epidual anesthesia
– Abdomen is insufflated with carbon dioxide
– One or more trochars are inserted into the
peritoneum near the umbilicus & symphysis
pubis
– Laparoscope visualizes structures in the pelvis
– Can perform certain surgical procedures
Assessment of the uterine cavity
Modalities to assess the uterine cavity include
• Saline Infusion Sono-hysterography (SIS)
• Three dimensional sonography
• Hysterosalpingography (HSG)
• Hysteroscopy
Investigations NOT indicated in
clinical practice
• Serum antisperm antibody
• Postcoital test
• Sperm function test
• Endometrial biopsy
• Hysteroscopy
• Ultrasound of endometrium
Treatment of female infertility
General advice
• folic acid whilst trying to conceive and
during the first 12 wks of pregnancy to
prevent neural tube defects
• Reduce body weight in obese women
• Stop smoking
• Avoid excessive alcohol
Good health
Free from illness eg thyroid, blood pressure,
diabetes
Avoid food fads
Balanced diet
Folic Acid
Supplements
Mangement of Anovulation
Management of Hypothalamic
pituitary failure
Amenorrhea or severe oligomenorrhea
FSH & LH: low
Prolactin: normal
• 1. Reverse the life style factors:
• Increase wt if BMI <19
• Moderating exercise if high levels of exercise.
• Treat stress
• 2. Gonadotrphins with LH activity or Pulsatile
GnRH (pump)
Management of PCOS
Weight reduction
Drugs
• Clomiphene citrate
• Gonadotrophin releasing hormone
• Gonadotrophin
• Others: insulin sensitising agents (metformin)
• Letrozole
Surgery
• ovarian drilling
Clomiphene Citrate (cc)
• 1) Starting dose is 50 mg daily for 5 days, can be started
b/t day 2- 6 of menses,
• 2) Check for ovulation
• 3) If there is ovulation, continue the same dose for 3-6
cycles, either with timed coitus or with IUI.
• 4) No response, increase dose by 50 mg in each cycle,
until a maximum of 150mg per day.
• 5) If no response to the maximum dose, further increase
is not effective
Gonadotrophin therapy
In women with PCOD
Aim:
• Ripen follicles with repeated doses of FSH
• Stimulate ovulation with injection of LH or hCG
Drugs in use:
• HMG– 75 IU FSH, 25-75 iu LH
• Urofollitrophin—75 IU FSH n almost no LH
• Recombinant FSH—75 IU FSH
• hCG—1000-5000 IU hCG
Insulin sensitizing drug
Management of Resistant PCOS
Management of Tubal Factors
Tubal surgery
• microsurgical technique
• laparotomy or laparoscopy
• adhesiolysis, re-anastomosis,
salpingostomy
• In vitro fertilization and embryo transfer
(IVF-ET)
Management of Uterine Factors
Myomectomy indications
Management of Uterine Factors
• Septate uterus
Not increased among women with infertility
compared with other women (2–3%).
More common: RM or PTL.
• Hysteroscopic metroplasty:
Management of Uterine Factors
Intrauterine adhesions with amenorrhoea
• hysteroscopic adhesiolysis
Management of unexplained
infertility
Assisted Reproductive
Technologies (ART)
• IVF-in vitro fertilization and embryo
transfer
• GIFT-gamete intrafallopian tube transfer
• ZIFT-zygote intrafallopian tube transfer
• ICSI - Intracytoplasmic sperm injection
INVITRO FERTILIZATION
(IVF)
Indications
• - Severe tubal damage/ blockage.
• - Bilateral salpingectomy.
• - Endometriosis.
• - Mild male infertility.
• - Unexplained infertility.
• - Immunologic infertility..
• Success rate: About 20-30%
Basic Steps in IVF
• Ovary stimulation
• Egg retrieval
• Sperm retrieval-wash sperm
• Fertilization
• Embryo transfer
• Progesterone
Drugs used for ovary stimulation
• Clomiphene (clomid)-anti-estrogen
• hMG (pergonal)-menopausal gonadotropin (FSH
and LH)
• FSH-(metrodin)
• GnRH
• GnRH agonists (lupron)-FSH/LH first promoted,
then inhibited hCG-acts like LH
Egg retrieval
Sperm Retrieval Techniques
• MESA – microsurgical epididymal sperm
aspiration.
• PESA – percutaneous epididymal sperm
aspiration.
• TESE – testicular sperm extraction.
• Gametes mixed for GIFT
GIFT
GIFT
ZIFT
ZIFT
Intracytoplasmic sperm injection
ICSI
ICSI
ICSI
• Indication : (Male factors)
• - Oligozoospermia.
• - Asthenospermia.
• - Teratozoospermia.
• - Antisperm Ab.
• - Fertilization failure after conventional IVF.
• - Ejaculatory disorder
IVF Side Effects
• Cysts on the ovaries
• Multiple births
• Ovarian Hyperstimulation
• Risk of ovarian cancer
Alternatives to Childbirth
• Adoption
• Surrogate mothers
• Frozen embryos
• Egg donors
• Frozen eggs
• Cloning
Infertility ppt

More Related Content

Similar to Infertility ppt

Infertility
Infertility Infertility
Infertility
Appy Akshay Agarwal
 
male infertility
male infertilitymale infertility
male infertility
Snehlata Parashar
 
New microsoft office power point presentation
New microsoft office power point presentationNew microsoft office power point presentation
New microsoft office power point presentation
Snehlata Parashar
 
In Vitro Fertilization (IVF) : Today and tomorrow
In Vitro Fertilization (IVF) : Today and tomorrowIn Vitro Fertilization (IVF) : Today and tomorrow
In Vitro Fertilization (IVF) : Today and tomorrow
Anu Test Tube Baby Centre
 
Male infertility by Dr. Preksha Jain
Male infertility by Dr. Preksha JainMale infertility by Dr. Preksha Jain
Male infertility by Dr. Preksha Jain
Dr. Preksha Jain
 
Male infertility
Male infertilityMale infertility
Male infertility
TanmoyDebnath17
 
Assessment of infertility using hystero laparoscopy
Assessment of infertility using hystero laparoscopyAssessment of infertility using hystero laparoscopy
Assessment of infertility using hystero laparoscopy
Niranjan Chavan
 
Infertility [Dr. Edmond Wong]
Infertility [Dr. Edmond Wong]Infertility [Dr. Edmond Wong]
Infertility [Dr. Edmond Wong]
Edmond Wong
 
Femelife fertility
Femelife fertilityFemelife fertility
Femelife fertility
sunitafeme
 
nursing 8.pdf
nursing 8.pdfnursing 8.pdf
nursing 8.pdf
ahmedhassan756265
 
Uterine fibroids
Uterine fibroidsUterine fibroids
Uterine fibroids
Dr. Preksha Jain
 
male infertility.pptx
male infertility.pptxmale infertility.pptx
male infertility.pptx
AnupamAnand59
 
infertility
infertility infertility
infertility
Saber Lahmidi
 
Cervical precancerous lesions and cervical cancer
Cervical precancerous lesions and cervical cancerCervical precancerous lesions and cervical cancer
Cervical precancerous lesions and cervical cancer
Marmara University School of Medicine
 
Subfertility.pptx
Subfertility.pptxSubfertility.pptx
INFERTILITY.pptx
INFERTILITY.pptxINFERTILITY.pptx
INFERTILITY.pptx
ssuser9083fe
 
Infertility
InfertilityInfertility
Evaluation of male infertility
Evaluation of male infertility Evaluation of male infertility
Evaluation of male infertility
SomendraBansal
 
Evaluation of male infertility.
Evaluation of male infertility.Evaluation of male infertility.
Evaluation of male infertility.
PritamMandal18
 

Similar to Infertility ppt (20)

Infertility
Infertility Infertility
Infertility
 
male infertility
male infertilitymale infertility
male infertility
 
New microsoft office power point presentation
New microsoft office power point presentationNew microsoft office power point presentation
New microsoft office power point presentation
 
In Vitro Fertilization (IVF) : Today and tomorrow
In Vitro Fertilization (IVF) : Today and tomorrowIn Vitro Fertilization (IVF) : Today and tomorrow
In Vitro Fertilization (IVF) : Today and tomorrow
 
Male infertility by Dr. Preksha Jain
Male infertility by Dr. Preksha JainMale infertility by Dr. Preksha Jain
Male infertility by Dr. Preksha Jain
 
Male infertility
Male infertilityMale infertility
Male infertility
 
Assessment of infertility using hystero laparoscopy
Assessment of infertility using hystero laparoscopyAssessment of infertility using hystero laparoscopy
Assessment of infertility using hystero laparoscopy
 
Infertility [Dr. Edmond Wong]
Infertility [Dr. Edmond Wong]Infertility [Dr. Edmond Wong]
Infertility [Dr. Edmond Wong]
 
Femelife fertility
Femelife fertilityFemelife fertility
Femelife fertility
 
MSc Embryo implantation lecture
MSc Embryo implantation lectureMSc Embryo implantation lecture
MSc Embryo implantation lecture
 
nursing 8.pdf
nursing 8.pdfnursing 8.pdf
nursing 8.pdf
 
Uterine fibroids
Uterine fibroidsUterine fibroids
Uterine fibroids
 
male infertility.pptx
male infertility.pptxmale infertility.pptx
male infertility.pptx
 
infertility
infertility infertility
infertility
 
Cervical precancerous lesions and cervical cancer
Cervical precancerous lesions and cervical cancerCervical precancerous lesions and cervical cancer
Cervical precancerous lesions and cervical cancer
 
Subfertility.pptx
Subfertility.pptxSubfertility.pptx
Subfertility.pptx
 
INFERTILITY.pptx
INFERTILITY.pptxINFERTILITY.pptx
INFERTILITY.pptx
 
Infertility
InfertilityInfertility
Infertility
 
Evaluation of male infertility
Evaluation of male infertility Evaluation of male infertility
Evaluation of male infertility
 
Evaluation of male infertility.
Evaluation of male infertility.Evaluation of male infertility.
Evaluation of male infertility.
 

Recently uploaded

Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 

Infertility ppt

  • 2. DEFINITION • After one year of frequent, unprotected sexual intercourse there is no conception or maintenance of pregnancy • INCIDENCE : 15 – 30% couples
  • 3. SUBFERTILITY • Inability to conceive after one year of regular unprotected intercourse in the absence of known reproductive pathology. • Peak monthly pregnancy rate ~ 30% • Cumulative rate in 1 year ~ 85% • Cumulative rate in 2 years ~ 95%
  • 4. • FECUNDABILITY : probability that a cycle will result in pregnancy. • FECUNDITY : probability that a cycle will result in a live birth. • In a normal fertile couple - 20% to 30%
  • 5. Types of Infertility • PRIMARY INFERTILITY: Patients who have never conceived • SECONDARY INFERTILITY : Previous pregnancies but failure to conceive subsequently
  • 6. ETIOLOGY • Male factors: 30% • Female: 45% • Tubal: 20% • Ovulatory disorders: 25% • Uterine: 10% • Endometriosis: 5% • Unexplained:25% • Combined male and female: 40%
  • 7. SPERMATOGENESIS • 74 days from spermatocyte stage • Transport 12-21 days
  • 9. Causes of Male Infertility • 1. IDIOPATHIC (40-50%) • 2. HYPOTHALAMIC & PITUITARY DISORDERS (1-2%) Pre – Testicular • 3. PRIMARY GONADAL DISORDERS (30-40%) Testicular • 4. SPERM TRANSPORT DISORDERS (10- 20%) Post - Testicular
  • 10. PRE – TESTICULAR CAUSES Hypothalamic & pituitary disorders (1-2%) CONGENITAL • Idiopathic isolated gonadotropin deficiency(M/C) • Kallmann syndrome • Single gene mutations • Multiorgan genetic disorders: PraderWilli syndrome Laurence Moon Beidl syndrome. ACQUIRED • • Hth & pit tumors • • Infilterative diseases • • Hyperprolactinemia • • Drugs • • Critical illness • • Chronic systemic illness • • Infections • • Obesity
  • 11. TESTICULAR CAUSES Primary gonadal disorders (30-40%) • CONGENITAL • Klinefelter syndrome • Y chromosome deletions • Single gene mutations • Cryptorchidism • Varicoceles • Androgen insensitivity syndromes • 5 alpha reductase deficiency • ACQUIRED • Infection(mumps orchitis) • Drugs • Radiation • Gonadotoxins • Chronic illness • Hyperthermia • Immunologic disorders • Trauma • Torsion • Castration
  • 12. Post Testicular causes SPERM TRANSPORT DISORDERS (10-20%) • • Epididymal obstruction or dysfunction • • Hypospadias • • CBAVD • • Infections • • Vasectomy, herniorraphy • • Kartagener syndrome • • Young syndrome • • Ejaculatory dysfunction
  • 13. MALE INFERTILITY EVALUATION • ●History • ●Examination • ●Investigation • 1. Conventional Semen analyses • 2. Specialized Semen analysis • 3. Endocrine testing • 4. Genetic tests
  • 14. HISTORY Focuses on causes of infertility. • Personal: Age, occupation, special habits • Present: Type of infertility, duration • Sexual: Frequency, erection, ejaculation, dysparunia, habits, libido.
  • 15. History Past: • Medical: Chronic medical illness Infections: mumps orchitis, sinopulmonary symptoms, STI, and GUI (prostatitis) • Surgical: inguinal and scrotal areas such as vasectomy, orchiectomy, and herniorrhaphy • Trauma • Developmental: testicular descent, pubertal development, loss of body hair, or decrease in shaving frequency
  • 16. History • Drugs and environmental exposures alcohol, radiation therapy, anabolic steroids, cytotoxic chemotherapy, drugs that cause hyperprolactinemia, exposure to toxic chemicals. • School performance : determine if he has a history of learning disabilities
  • 17. Examination • General physical examination : general built , nutrition, skin & hair, sec sexual characteristics, habitus & breast development. • Examination of penis, location of urethral meatus • Palpation of testes & size • Presence & consistency of vas & epididymis • Digital rectal Examination
  • 18. Semen analysis A. Macroscopic • 1. Delayed liquefaction • 2. Increased viscosity • 3. Semen volume • 4. pH B. Microscopy • 1. Agglutination • 2. Concentration • 3. Motility • 4. Morphology • 5. Round cells • 6. Leukocytes
  • 19. Normal Semen Analysis Results (WHO) • Volume >2ml • pH 7-8 • Concentration >20 x 106/ml • Motility >50% forward & >25% with rapid linear progress • Morphology > 15% normal • Alive > 50% • Antisperm antibodies Negative • WCC < 1x106
  • 20. • II. SPECIALIZED SEMEN ANALYSIS Not routinely performed used to determine the cause of male infertility • 1. Sperm autoantibodies • 2. Semen Fructose • 3. Semen culture • 4. Sperm function tests CASA SDNAF
  • 21. Investigations • III. ENDOCRINE TESTS 1. Testosterone 2. LH and FSH 3. Prolactin • IV. GENETIC TESTS 1. Karyotyping 2. Y chromosome microdeletions 3. Cystic fibrosis conductance regulator (CFTR) gene mutation
  • 23. Abnormalities of Semen Analysis • Azoospermia : Complete absence of sperm on std microscopic examination in ejaculate. • Oligospermia : sperm density < 20 million/ml.
  • 24. • Asthenospermia : Poor sperm motility. • Teratospermia : > 70% abnormal morphology. • Necrospermia : dead sperm. • Leucocytospermia > 1million leucocytes/ml
  • 25. Urologic evaluation • Physical examination • TRUS (transrectal usg for duct obstruction) • Transscrotal Usg • Renal Scan • Testis Biopsy in azoospermic men • Vasogram
  • 26. MEDICAL TREATMENT Hypogonadotropic Hypogonadism: • Hyperprolactinoma- Dopamine agonists • Cong hypogonadotropic hypogonadism- hCG or exogenous testosterone • Adult onset hypogonadotropin hypogonadism- hCG 2000-5000 IU 3 times per week. Hypogonadotropin hypogonadism unrelated to cause- Portable programmable pulsatile infusion pump s/c
  • 27. Eugonadotropin Hypogonadism • Severe oligospermia • Low Sr. testosterone • T/t by aromatase inhibitor (Testolactone 50- 100 mg BD or Anastrazole 1 mg OD)
  • 28. Hypergonadotropic Hypogonadism • Insemination with donor sperm • IVF with ICSI with preliminary genetic evaluation Erectile dysfunction :Sildenafil- 25-100mg 1hr before intercourse
  • 29. Retrograde Ejaculation- • Sympathomimetics, pseudoephidrine, ephedrine • IVF & IUI & ICSI Leucocytospermia- • Antibiotics (doxycycline, erythromycin, cotrimoxazole Idiopathic Male Infertility- • Androgen therapy • Exogenous FSH • Clomiphene citrate (25 mg)/Tamoxifen (20 mg)
  • 30. SURGICAL TREATMENT 1. Vasovasostomy & vasoepididymostomy- In vasectomized men 2. Transurethral resection of the ejaculatory ducts- in men with Ejaculatory duct obstruction. 3. Varicocele repair- In men with varicoceles. 4. Orchipexy – In cryptorchidism 5. Vibratory stimulation & Electroejaculation – In neurological dysfunctions
  • 31. 3-Reproductive Technique (ART) • I- Intrauterine Insemination (IUI) • II- IVF/ICSI
  • 32. ARTIFICIAL INSEMINATION • Indications : • Oligospermia, • Asthenospermia, • Premature or retrograde ejaculation, • Sperm autoantibodies & cervical factors, • Unexplained infertility • Sex selection in genetic & chromosomal anomalies • Hypospadias • HIV positive
  • 33. Types: • 1. IUI • 2. Intracervical • 3. Pericervical & Vaginal • 4. DIPI (Direct intraperitoneal insemination
  • 34. Implementation and Collaborative Care • Sperm Washing for Intrauterine Insemination (IUI) – Ejaculate is centrifuged to concentrate sperm, which are then rinsed with saline to remove the seminal fluid – Sperm are again centrifuged, and then used for either IVF or Intrauterine artificial insemination
  • 35. IUI
  • 36. Implementation and Collaborative Care • Intrauterine Insemination (a form of artificial insemination) – Sperm are collected within 3 hours of colitus and are inserted via a catheter into the uterus – Donor sperm may be used – Identify of the sperm donor is kept confidential
  • 37. Donor Sperm INDICATIONS : • 1. Azoospermia • 2. Immunological factors not correctable • 3. Genetic disease in husband
  • 38. Female infertility • ovulatory dysfunction • tubal and peritoneal factors • cervical factors • Uterine factors • others • unexplained infertility
  • 39.
  • 40. Ovarian disorders Ovulatory disorders: Infrequent ovulation (oligoovulation) or absent ovulation (anovulation) Oocyte aging: Ovarian cysts:
  • 41.
  • 42.
  • 43. PCOS Rotterdam Criteria (2 out of 3) Menstrual irregularity due to anovulation or oligo-ovulation Evidence of clinical or biochemical hyperandrogenism Polycystic ovaries by US • presence of 12 or more follicles in each ovary measuring 2 to 9 mm in diameter and/or increased ovarian volume.
  • 44. Ovarian failure Causes • 1. Idiopathic. • 2. Genetic. • 3. Autoimmune • 3. Viral/bacterial infection • 4. Pelvic surgery, chemotherapy • 5. Galactosemia
  • 45. Tubal factors • Tubal disease and pelvic adhesions prevent normal transport of the oocyte and sperm through the fallopian tube. • PID • Severe endometriosis • Previous surgery or non-tubal infection (eg, appendicitis, inflammatory bowel disease), • Pelvic TB
  • 46.
  • 48. Uterine factors Impaired implantation, either mechanical or due to reduced endometrial receptivity, are the basis of uterine causes of infertility. Uterine leiomyomata:A meta-analysis showed that only leiomyomata with a submucosal or intracavitary component were associated with lower pregnancy and implantation rates.
  • 49. Uterine anomalies; Uterine abnormalities are thought to cause infertility by interfering with normal implantation. Müllerian anomalies are a significant cause of (RPL), with the septate uterus associated with the poorest reproductive outcome . Other structural abnormalities endometrial polyps synechiae from prior pregnancy related curettage.
  • 50. CERVICAL FACTORS Normal midcycle cervical mucus facilitates the transport of sperm. Congenital malformations and trauma to the cervix (including surgery) may result in stenosis and inability of the cervix to produce normal mucus, thereby impairing fertility.
  • 51. UNEXPLAINED Unexplained infertility is the diagnosis given to couples after a thorough evaluation has not revealed a cause. Many cases of unexplained infertility may be due to small contributions from multiple factors.
  • 52. History-General • Both couples should be present • Age • Previous pregnancies by each partner • Duration of infertility • Sexual history Frequency and timing of intercourse Use of lubricants Impotence, dyspareunia • Contraceptive history
  • 53. History-Female • Previous female pelvic surgery • PID • Appendicitis • IUD use • Ectopic pregnancy history • Endometriosis • Leiomyoma
  • 54. History • Irregular menses, amenorrhea, detailed menstrual history • Molimina • Vasomotor symptoms • Changes of hair growth, breast discharge • Stress • Weight changes • Exercise-drug –radiation -chemotherapy • Cervical and uterine surgery
  • 55. Physical Exam-Female • Thyroid exam • BMI • Hair distribution • Galactorrhea • Scar in the abdomen • Pelvic masses • Uterosacral nodularity • Abdominopelvic tenderness • Uterine enlargement • Uterine mobility • Cervical abnormalities • Abnormal vaginal discharge
  • 56. Investigations Assessment of ovulation • Basal body temperature • Urine LH kits • Mid luteal serum progesterone • Routine hormonal profile: FSH, LH,Prolactin,TSH • Endometrial biopsy • Serial pelvic Ultrasonography
  • 57.
  • 58. • Evidence of ovulation: 1. Menstrual history of regular cycles. 2. Serum progesterone in the mid-luteal phase of their cycle (day 21 of a 28-day cycle) even if they have regular menstrual cycles. 3. Serum gonadotrophins ( FSH & LH) on Day2-3 especially in irregular periods. No role for basal body temperature
  • 59. Ovarian reserve tests More important in >35 years old, suspected ovarian failure and to detect response to ovulation induction. • 1. Total antral follicle count. • 2. AMH of less than or equal to 5.4 pmol/l for a low response and greater than or equal to 25 pmol/l for a high response • 3. FSH greater than 8.9 IU/l for a low response and less than 4 IU/l for a high response.
  • 61. Investigations of tubal factor • Hysterosalpingography (HSG) • Hysterosalpingo-contrast sonography(HyCoSy) • Laparoscopy with chromotubation • Hydrolaparoscopy. • Fluoroscopic/hysteroscopic- selective tubal cannulation. • Falloposcopy
  • 62. Diagnostic Studies – Female • Hysterosalpingogram (HSG) – Detects uterine anomalies (septate, unicornate, bicornate) – Detects Tubal anomalies or blockage – Iodine-based radio-opaque dye is instilled through a catheter into the uterus and tubes to outline these structures and x-rays are taken to document findings
  • 64. HSG
  • 65. Diagnostic Studies – Female • Laparoscopy – General or epidual anesthesia – Abdomen is insufflated with carbon dioxide – One or more trochars are inserted into the peritoneum near the umbilicus & symphysis pubis – Laparoscope visualizes structures in the pelvis – Can perform certain surgical procedures
  • 66.
  • 67.
  • 68. Assessment of the uterine cavity Modalities to assess the uterine cavity include • Saline Infusion Sono-hysterography (SIS) • Three dimensional sonography • Hysterosalpingography (HSG) • Hysteroscopy
  • 69. Investigations NOT indicated in clinical practice • Serum antisperm antibody • Postcoital test • Sperm function test • Endometrial biopsy • Hysteroscopy • Ultrasound of endometrium
  • 70.
  • 71.
  • 72. Treatment of female infertility General advice • folic acid whilst trying to conceive and during the first 12 wks of pregnancy to prevent neural tube defects • Reduce body weight in obese women • Stop smoking • Avoid excessive alcohol
  • 73. Good health Free from illness eg thyroid, blood pressure, diabetes Avoid food fads Balanced diet Folic Acid Supplements
  • 75. Management of Hypothalamic pituitary failure Amenorrhea or severe oligomenorrhea FSH & LH: low Prolactin: normal • 1. Reverse the life style factors: • Increase wt if BMI <19 • Moderating exercise if high levels of exercise. • Treat stress • 2. Gonadotrphins with LH activity or Pulsatile GnRH (pump)
  • 76. Management of PCOS Weight reduction Drugs • Clomiphene citrate • Gonadotrophin releasing hormone • Gonadotrophin • Others: insulin sensitising agents (metformin) • Letrozole Surgery • ovarian drilling
  • 77. Clomiphene Citrate (cc) • 1) Starting dose is 50 mg daily for 5 days, can be started b/t day 2- 6 of menses, • 2) Check for ovulation • 3) If there is ovulation, continue the same dose for 3-6 cycles, either with timed coitus or with IUI. • 4) No response, increase dose by 50 mg in each cycle, until a maximum of 150mg per day. • 5) If no response to the maximum dose, further increase is not effective
  • 78. Gonadotrophin therapy In women with PCOD Aim: • Ripen follicles with repeated doses of FSH • Stimulate ovulation with injection of LH or hCG Drugs in use: • HMG– 75 IU FSH, 25-75 iu LH • Urofollitrophin—75 IU FSH n almost no LH • Recombinant FSH—75 IU FSH • hCG—1000-5000 IU hCG
  • 81. Management of Tubal Factors Tubal surgery • microsurgical technique • laparotomy or laparoscopy • adhesiolysis, re-anastomosis, salpingostomy • In vitro fertilization and embryo transfer (IVF-ET)
  • 82. Management of Uterine Factors Myomectomy indications
  • 83. Management of Uterine Factors • Septate uterus Not increased among women with infertility compared with other women (2–3%). More common: RM or PTL. • Hysteroscopic metroplasty:
  • 84. Management of Uterine Factors Intrauterine adhesions with amenorrhoea • hysteroscopic adhesiolysis
  • 86. Assisted Reproductive Technologies (ART) • IVF-in vitro fertilization and embryo transfer • GIFT-gamete intrafallopian tube transfer • ZIFT-zygote intrafallopian tube transfer • ICSI - Intracytoplasmic sperm injection
  • 87. INVITRO FERTILIZATION (IVF) Indications • - Severe tubal damage/ blockage. • - Bilateral salpingectomy. • - Endometriosis. • - Mild male infertility. • - Unexplained infertility. • - Immunologic infertility.. • Success rate: About 20-30%
  • 88. Basic Steps in IVF • Ovary stimulation • Egg retrieval • Sperm retrieval-wash sperm • Fertilization • Embryo transfer • Progesterone
  • 89. Drugs used for ovary stimulation • Clomiphene (clomid)-anti-estrogen • hMG (pergonal)-menopausal gonadotropin (FSH and LH) • FSH-(metrodin) • GnRH • GnRH agonists (lupron)-FSH/LH first promoted, then inhibited hCG-acts like LH
  • 91. Sperm Retrieval Techniques • MESA – microsurgical epididymal sperm aspiration. • PESA – percutaneous epididymal sperm aspiration. • TESE – testicular sperm extraction.
  • 92. • Gametes mixed for GIFT
  • 93. GIFT
  • 94. GIFT
  • 95. ZIFT
  • 96. ZIFT
  • 98. ICSI
  • 99. ICSI • Indication : (Male factors) • - Oligozoospermia. • - Asthenospermia. • - Teratozoospermia. • - Antisperm Ab. • - Fertilization failure after conventional IVF. • - Ejaculatory disorder
  • 100. IVF Side Effects • Cysts on the ovaries • Multiple births • Ovarian Hyperstimulation • Risk of ovarian cancer
  • 101. Alternatives to Childbirth • Adoption • Surrogate mothers • Frozen embryos • Egg donors • Frozen eggs • Cloning